Please login to the form below

salmeterol

This page shows the latest salmeterol news and features for those working in and with pharma, biotech and healthcare.

FDA hands GSK a reprieve by blocking Novartis generic

All three generics have been flummoxed by the complexity of Advair (salmeterol and fluticasone propionate) and the difficulty of showing sufficient equivalence with the Diskus dry powder inhaler used in the ... Teva won approval for its AirDuo product

Latest news

Gilead’s triple HIV drug approval prompts GSK lawsuit

vaccine Shingrix and recently-approved triple therapy for chronic obstructive pulmonary disorder (COPD) Trelegy - as it faces the imminent threat of generic competition to its big-selling respiratory drug Advair (salmeterol
AZ’s COPD triple data sets up market clash with GSK

salmeterol and fluticasone propionate) that was a $7bn product at its peak but has seen sales slip of late, coming in at $3.3bn in the first nine months of 2017.
EMA approves GSK’s triple COPD therapy

GSK has a lot riding on Trelegy as it tries to grow its respiratory business, which has been hit by patent expiries for COPD blockbuster Seretide/Advair (salmeterol and fluticasone propionate) -
CDC backs GSK’s Shingrix over Merck & Co’s Zostavax

That helped offset continued declines for GSK’s past-its-prime asthma and chronic obstructive pulmonary disease (COPD) therapy Advair/Seretide (fluticasone propionate/salmeterol), which saw sales decline 7% to
With US approval, GSK now needs rapid uptake for COPD triple

fluticasone propionate/salmeterol) which brought in $7bn a year for GSK at peak but contracted to $2.2bn in the first half of the year thanks to generic competition.

More from news
Approximately 1 fully matching, plus 94 partially matching documents found.

Latest from PMHub

Raising Awareness: It’s World COPD Day today!

Common combinations include fluticasone proprionate/salmeterol and budesonide/formoterol, which are taken twice-daily, and fluticasone furoate/vilanterol, which is taken once-daily (5).

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Senior Account Manager / Account Director: Great salary and bebefits

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Medical Writer, e-learning/ training, London: Excellent Salary

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Editor – Medical Education Agency – Bucks: Salary TBC

Scientific Director: Great salary and bebefits

Senior Programme Executive: Salary TBC

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Senior Account Manager – Med Comms – Kent: Salary TBC

Senior Account Manager or AD - Medical Communications: Salary TBC

Editorial Director – Medical Education – Oxford: Negotiable

Group Account Director, Healthcare Brand Communications, London: Excellent Package

Medical Writer - (London, Brighton or Copenhagen): Competitive

Senior Medical Writer: Great salary and benefits

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

Senior Account Director, Healthcare Brand Communications, London: Excellent Package

Subscribe to our email news alerts

PMHub

Add my company

FCB Halesway

A Eureka moment! A converted dairy in the Hampshire countryside back in 1993 saw the inception of Halesway as a...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement: Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...